Akebia Therapeutics
Latest round
- Series C
Last raised
- Jun 2013
Total raised
- $83M
Investors
- 12
About Akebia Therapeutics
Akebia Therapeutics, Inc.Founded in 2007 and headquartered in Cambridge, US, Akebia Therapeutics is focused on developing treatments for CKD.00 mn.Akebia Therapeutics is a fully integrated biopharmaceutical company that offers two FDA-approved products designed to improve outcomes for individuals suffering from chronic kidney disease (CKD).77 mn. The company aims to expand its reach into international markets with targeted growth planned through 2025.00 mn in May 2020, which will enable further investments in product innovation and market expansion.
Who invested in Akebia Therapeutics
12 investors across 6 rounds
See all investors in Akebia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Akebia Therapeutics
Who invested in Akebia Therapeutics?
Akebia Therapeutics has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Akebia Therapeutics raised?
Akebia Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Akebia Therapeutics last raise money?
Akebia Therapeutics's most recent round on record is a Series C, in Jun 2013.
What does Akebia Therapeutics do?
Akebia Therapeutics is a biotechnology company.
Where is Akebia Therapeutics headquartered?
Akebia Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Akebia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Akebia Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Akebia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.